Bioalmanac
Epitalon
Epithalon · Ala-Glu-Asp-Gly · AEDG peptide
A four-amino-acid peptide studied almost exclusively by one Russian research group, best known for claims about telomerase activation.
Storage
- Freeze-dried powder
- Refrigerated at 2–8 °C, protected from light.
- After mixing
- Refrigerated at 2–8 °C. Do not freeze once mixed.
- Long-term, frozen
- Unopened powder is stable at −20 °C or colder.
Reconstitution — 50 mg vial, 10000 mcg dose
On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.
| Water added | Concentration | Volume to draw | Units | Doses per vial |
|---|---|---|---|---|
| 1 mL | 50 mg/mL | 0.2 mL | 20 units | 5 |
| 2 mL | 25 mg/mL | 0.4 mL | 40 units | 5 |
| 3 mL | 16.667 mg/mL | 0.6 mL | 60 units | 5 |
| 5 mL | 10 mg/mL | 1 mL | 100 units | 5 |
Dose ranges reported in sources
Descriptions of what sources report, not recommendations.
| Goal | Range | Frequency | Source |
|---|---|---|---|
| Commonly described course | 5000–10000 mcg | Daily for 10 to 20 days, then a long break | Community practice |
When to stop
- Any new lump or growth. Given that the compound's headline claim is telomerase activation, this warrants prompt investigation rather than watching.
- Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
- Signs of infection at an injection site.
- Marked changes in sleep or mood that persist beyond the first few days.
Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.